SYSTEMIC contact dermatitis was uncommon despite frequent patch test positivity in patients with suspected eczema patterns.
A prospective study of 100 patients found that 40% had at least one positive patch test, yet only two patients met the prespecified clinical criteria for systemic contact dermatitis. The findings highlight the importance of distinguishing allergen sensitization from clinically relevant systemic disease when evaluating persistent or unusual eczema.
Systemic Contact Dermatitis Remains Uncommon
Researchers evaluated consecutive patients aged 12 years or older presenting with four eczema patterns historically associated with systemic contact dermatitis: nonspecific eczema, pompholyx, recalcitrant hand eczema, and symmetrical drug related intertriginous flexural exanthema like eruptions.
The cohort had a mean age of 37.7 years, and 59% were female. Nonspecific eczema was the most frequent presentation, affecting 38% of patients, followed by pompholyx in 32% and hand eczema in 29%. One patient had an SDRIFE like eruption.
All patients underwent detailed exposure assessment, Indian Standard Series patch testing, and COADEX relevance grading. A diagnosis of systemic contact dermatitis required a relevant positive patch test, documented systemic exposure to the allergen, and a temporal relationship between that exposure and eczema flares.
Positive Patch Tests Do Not Equal Systemic Disease
Patch testing produced positive results in 40 patients. Para phenylenediamine was the most common sensitizer, identified in 13%, followed by nickel and parthenium at 9% each and potassium dichromate at 8%.
Despite this frequency of contact sensitization, only two women met the study criteria for systemic contact dermatitis, representing 2% of the cohort. One nickel associated case was classified as clinically definite, while one garlic associated case was considered probable.
No systemic contact dermatitis cases were identified among patients with pompholyx or hand eczema.
Exposure History Adds Clinical Context
The results suggest that a positive patch test alone may not establish systemic contact dermatitis. Linking sensitization with a plausible systemic exposure and the timing of subsequent eczema flares appears important when determining clinical relevance.
For clinicians evaluating recurrent or difficult eczema patterns, the findings support targeted patch testing alongside structured exposure assessment rather than interpreting sensitization in isolation. The authors noted that larger prospective multicenter studies are needed to refine diagnostic criteria and determine the true burden of systemic contact dermatitis.
Reference
Garg V et al. Patch Test Relevance and Systemic Exposure Pathways in Eczema Patterns Suspected of Systemic Contact Dermatitis. Contact Dermatitis. 2026. doi:10.1111/cod.70258.
Featured Image: Media on Adobe Stock.